Stocklytics Platform
Asset logo for symbol MCK
McKesson
MCK65
$488.78arrow_drop_down1.94%-$9.70
S&P500
Asset logo for symbol MCK
MCK65

$488.78

arrow_drop_down1.94%

Income Statement (MCK)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT$1.06B$1.37B$680.00M$846.00M$1.34B
EBITDA$1.23B$1.53B$839.00M$1.00B$1.34B
gross Profit$2.95B$3.46B$3.15B$3.06B$3.02B
NET Income$915.00M$791.00M$589.00M$664.00M$958.00M
total Revenue$79.28B$76.35B$80.89B$77.21B$74.48B

Balance Sheet (MCK)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents---$2.52B$2.63B
net Debt$5.09B$2.80B$5.62B$4.79B$4.78B
stockholders Equity-$1.75B-$1.97B-$2.05B-$1.82B-$1.60B
total Assets$71.67B$67.44B$66.51B$66.09B$64.09B
total Debt$7.39B$7.39B$7.60B$7.31B$7.42B
total Liabilities$73.05B$69.04B$68.19B$67.55B$65.33B

Cash Flow (MCK)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow-$809.00M-$968.00M-$622.00M-$909.00M-$843.00M
free Cash Flow-$1.54B$3.87B$100.00M$825.00M-$1.17B
investing Cash Flow----$315.00M-$149.00M
operating Cash Flow-$1.38B$4.14B$254.00M$965.00M-$1.05B

McKesson (MCK) Financials

McKesson Corp (MCK) is a leading global healthcare company that provides pharmaceuticals, medical supplies, and healthcare information technology. As of the latest financial statement, McKesson Corp reported a total revenue of $231.0 billion. The company's gross profit for the same period stood at $6.8 billion. McKesson Corp recorded an operating income of $5.2 billion, indicating a strong financial performance. The net income attributable to stockholders was reported at $3.9 billion. This shows the company's ability to generate significant profits for its shareholders.
McKesson Corp's balance sheet reflects a healthy financial position. The company has total assets worth $62.8 billion. On the liabilities side, McKesson Corp has a total debt of $30.5 billion, which indicates a moderate debt burden. The stockholders' equity is reported at $17.2 billion, showcasing a solid financial foundation. The company also maintains cash equivalents of $3.6 billion, providing it with liquidity to meet its financial obligations. Additionally, McKesson Corp has a net debt of $26.9 billion, which takes into account the company's cash and cash equivalents.
In terms of cash flow, McKesson Corp has been effectively managing its finances. The operating cash flow for the latest period was $4.2 billion, demonstrating the company's ability to generate cash from its core operations. The investing cash flow stood at -$1.1 billion, primarily driven by investments in property, plant, and equipment. The financing cash flow was reported at -$2.7 billion, reflecting debt repayments and share repurchases. McKesson Corp's free cash flow, which represents the cash available for investment or distribution to stockholders, was $3.0 billion.
In summary, McKesson Corp (MCK) has shown strong financial performance with a substantial total revenue and gross profit. The company maintains a solid balance sheet with a healthy stockholders' equity and manageable debt levels. McKesson Corp has also demonstrated its ability to generate cash from operating activities and maintain a positive free cash flow. Overall, the financials portray McKesson Corp as a financially stable and successful healthcare company.
add McKesson to watchlist

Keep an eye on McKesson

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media